Question 1

Has Madeleine Pearson received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,361 in general payments to Madeleine Pearson across 74 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Madeleine Pearson did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Madeleine Pearson come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
BETA Bionics, Inc.	16	$188
Lilly USA, LLC	8	$161
Dexcom, Inc.	8	$141
AbbVie	6	$124
Sanofi-aventis U.S. LLC	4	$98
Medtronic	3	$72
Novo Nordisk	4	$70
Abbott	3	$64
Verity Pharmaceuticals Inc.	2	$53
Sequel Med Tech, LLC	2	$46
Novartis	2	$45
AstraZeneca	2	$44
Ascendis Pharma Endocrinology Inc	2	$43
Xeris Pharmaceuticals, Inc.	2	$37
Bayer	2	$36
Tandem Diabetes Care, Inc.	3	$36
Mannkind Corporation	2	$36
Amgen	1	$26
Esperion Therapeutics, Inc.	1	$21
Corcept Therapeutics	1	$19

Madeleine Pearson

Payments from drug & device makers

Who reported the general payments

How this compares

Other adult health in Saint Louis